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A B S T R A C T
Depression and anxiety are co-morbid condition in diabetes as disease-related psychological reactions on this chronic
metabolic illness. This study was aimed to determine the occurrence of depression and anxiety in seafarer’s type 2 dia-
betic patients. A random sample of 52 diabetic seafarers treated with diet and oral glucose lowering agents, and 56
healthy seafarers were screened for depression with The Beck Depression Inventory (BDI) and for anxiety with State-
-Trait Anxiety Inventory (STAI 1, STAI 2). Depression (BDI>18.5) and anxiety (STAI<28.5) was significantly higher in
the group of diabetic seafarers than in control group (more than 30%). Significant correlation was noted between depres-
sion and duration of diabetes mellitus, degree of obesity and poor glycaemic control (HbA1C>8%) and longer duration of
shipping routes (over 6 months). The proportion of depression and anxiety was found higher in seafarer’s type 2 diabetic
patients than in the healthy seafarers.
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Introduction
Depression and anxiety are prevalent co-morbid con-
dition in diabetes as disease-related psychological reac-
tions on this chronic metabolic illness. Among the pa-
tients with diabetes mellitus type 2, many studies have
documented the high rate of depression, compared with
no patient control subjects1. Anderson and colleagues
showed that risk of depression might be at least doubled
with diabetes compared to the general population2. The
number of type 2 diabetic patients, during the past sev-
eral decades, has greatly increased. Depression among
patients has been associated with decreased self-manage-
ment, poor metabolic control, and increased risk for dia-
betes-related complications3–6. These studies showed wi-
de variations in the rate of depression among patients
with diabetes due to differences in patient demographics,
disease characteristics, business occupation and other
factors that contribute to general psychological distress.
Seafaring is known as a dangerous occupation with a
high risk of fatal accidents in workplace7,8. The popula-
tion of seafarers has also been identified as additional
health-hazard group and as a group with high mortality
in general9. They have great responsibilities in working
with ships under various environmental conditions, which
cause general psychological distress of living with addi-
tional stress of having major chronic disease10–15. Tha
aim of this study was to determine the occurrence of de-
pression and anxiety in seafarers type 2 diabetic pa-
tients, and its association with glycaemic control, degree
of obesity and chronic microvascular complications. The
patients with cardiovascular complications were exclu-
ded.
Patients and Methods
The seafarers with type 2 diabetes treated with diet
and oral glucose lowering agents, were invited to partici-
pate in s study of psychosocial factors and diabetes dur-
ing the six months recruitment period. Individuals were
ineligible for this study if they had been diagnosed with
type 2 diabetes for less than one year or if, on independ-
ent review of their medical records (by a diabetologist),
individuals had history of microvascular complications.
The control group was healthy seafarers with similar
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sex, age and current life circumstances as seafarer. The
data of age and on current life circumstances as seafarer
(years on the ship, the duration of shipping routes during
one year) were collected by a semi-structured interview.
The subjects completed The Beck Depression Inven-
tory (BDI) and for anxiety with State-Trait Anxiety In-
ventory (STAI 1, STAI 2), all of which are well-known
validated self-complete questionnaires that have been
used extensively in many countries. These are short but
reliable screening tests to determine presence of depres-
sion and anxiety9,10. BDI scores were defined as moder-
ate-severe (scores>18.5), mild (scores 10–18.5) and low
(scores<10). Scores of 18.5 and higher on BDI have been
shown to approximate clinically significant levels of de-
pression9. The STAI is an instrument that includes sepa-
rate self-assessment scales measuring 2 independent
concepts of anxiety: state and trait. While state anxiety is
considered a transitory emotional condition, trait anxi-
ety is defined as a relatively stable tendency towards anx-
iety. 10-item short form of the state component of the
State Trait Anxiety Inventory was used to assess seafar-
ers’ anxiety with diabetes type 2 and healthy individuals,
and it was significant STAI score <28.5 levels at each of
the interviews10.
The data about duration of diabetes mellitus, body
mass index (BMI), glycaemic control, therapy of diabetes
and microvascular complications were recorded from the
patients medical records. Glycaemic control was mea-
sured by HbA1C, the normal range was <6.5%.
As statistical analyses, c2-test was used to examine
differences in prevalence rates of depression and anxiety
among these groups. For analyses other research ques-
tions (age, BMI, glycaemic control, duration of diabetes
mellitus, years on the ship and the duration of shipping
routes during the year) was utilized Student’s t-test for
comparing differences in means.
Results
We examined 52 seafarers with diabetes type 2 trea-
ted with diet and oral glucose lowering agents, mean age
43±8.2 years, body mass index (BMI) 30±8.2. The mean
duration of diabetes was 5.9±3.9 years, 36 patients was
treated with sulfonilureas and 16 with metformin. The
mean value of long-term retrospective parameter, glycated
hemoglobin HbA1C was 7.5±1.8%. The microvascular
complications were present in 21% patients. The data is
shown in Table 1.
The diabetic seafarers were compared to healthy sea-
farers with same psychological distress of living on the
ship (Table 2). There was no statistically significant dif-
ference between ages of these two groups. In healthy sea-
farers BMI (p<0.001) and years spend on the ship (p<
0.05) was significantly lower than in diabetic group. The
duration of shipping during one year was significantly
higher (p<0.05) in control group.
A random sample of 52 diabetic seafarers and 56
non-diabetic seafarers were screened for depression with
The Beck Depression Inventory (BDI) and for anxiety
with State-Trait Anxiety Inventory (STAI 1, STAI 2).
Depression (BDI scores>18.5) was present in 17/52
type 2 diabetic seafarers (34%). BDI scores was mild
(scores 10–18.5) in 11/52 diabetic seafarers and low (sco-
res<10) in 24/52 diabetic seafarers. Control group had
proportion of depression 6/56 (11%), mild levels depres-
sion 8/56 and normal levels 42/56 healthy seafarers. The
type 2 diabetic seafarers were more than twice as likely
to report depression compared to healthy seafarers; p=
0.002 (Figure 1).
Analysis of variance demonstrated that, for depres-
sive symptoms, mean BDI scores, although all in the mild
range, were significantly higher in diabetic group, with a
significant covariant effect of duration of diabetes (p=
0.005), BMI (p=0.03) and level of glycaemic control (p=
0.001). In both group, significantly effect on depressive
symptoms had duration of shipping routes during one
year (diabetic group p=0.004; control group p=0.02).
STAI score was used to measure the level of anxiety in
these two groups. It has been done STAI 1 (for state anxi-
ety which is transitory emotional condition) and STAI 2
(for trait anxiety which is relatively stable condition).
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TABLE 1
CHARACTERISTICS OF DIABETIC TYPE 2 SEAFARERS (N=52)
Duration of diabetes (years) 5.9±3.9
HbA1C (<6.5%) 7.5±1.8
BMI (kg/m²) 30±2.4
Therapy diet, oral glucose lowering agents
Microvascular complications 21%
TABLE 2
DEMOGRAPHIC CHARACTERISTICS OF THE SEAFARERS WITH
TYPE 2 DIABETES (DM) AND HEALTHY SEAFARERS (C)
DM (N=52) C (N=56)
Age (years) 43±8.2 42±6.2
BMI (kg/m²) 30±2.4 25±1.6**
Years on the ship 24±8.1 22±7.9*
Duration of shipping
during one year 6.65±2.3 7.4±3.1*











Fig. 1. Proportion of diabetic and healthy seafarers reporting
moderate-severe symptoms of depression (*p<0.05).
The significant STAI score<28.5 for anxiety was present
in 24/52 type 2 diabetic seafarers (46%). In control group
significant STAI score was present in 11/56 healthy sea-
farers (20%). The type 2 diabetic seafarers had more than
twice report compared to healthy seafarers; p= 0.001
(Figure 2). In both groups, there was a high correlation
between depressive symptoms and symptoms of anxiety.
Discussion
Depression and anxiety are associated with diabetes.
The complex interactions of physical, psychological, and
genetic factors that contribute to this association remain
uncertain. The prevalence of depression in diabetes from
39 studies is that diabetes doubles the odds of depres-
sion2. Depression may occur secondary to diabetes or to
diabetes-related abnormalities in neurohormonal or neu-
rotransmitter function16. Some prospective studies indi-
cate that depression doubles the risk of incident type 2
diabetes independent of its association with other risk
factors17. The depression rates were approximately two
to three times higher in studies that used self-report
measures vs. diagnostic interviews. These two approa-
ches identify somewhat different but overlapping sam-
ples of depressed individuals. Diagnostic interviews iden-
tify major depressive disorder but exclude other clinically
relevant presentations. Self-report measures can identify
most cases of major depressive disorder. Self-report mea-
sures may identify a broader spectrum of depression dis-
orders (e.g., dysthymic disorder, or minor or subsynd-
romal depression) or symptoms that reflect co morbid
psychiatric illness (e.g., anxiety or substance-abuse dis-
orders) or general distress.
Depression and anxiety for patients with diabetes are
not just predictors from diabetes-related stresses alone11.
Many variables can influence on depression and anxiety,
such are patient education, financial stress; stress at
work and in the family associated with poor conflict reso-
lution around diabetes2. It is necessary to view depres-
sion symptoms within the broad context of general psy-
chological distress and to observe psychological distress
within the broad context of general life functioning. Psy-
chological distress refers to the stresses associated with
work, finances, and family, as well as diabetes.
Work of seafarers is very complex because they must
be capable of carrying out their work in all situations far
away from home for long period18. The current periodic
examination system must prevent effectively possible
health defect from work and made to ensure their work-
ing capacity. There are few studies which explore the
influence of seafarer’s life on cardiovascular morbidity
and mortality19,20. Among seafarers there is high inci-
dence of factors for development of cardiovascular
disease21,22. One of them is diabetes mellitus type 2.
Psychological distress of living and having a major
chronic disease for cardiovascular morbidity made that
diabetes mellitus doubles the odds of depression. Stress
of seafarers depends on occupational group (higher in en-
gine crew), personally characteristics, work-related fac-
tors (noise, climatic conditions, received appreciation)
and free-time activities23–25. The aim of this study was to
determine the occurrence of depression and anxiety in
seafarers type 2 diabetic patients and its association with
glycaemic control, degree of obesity and chronic micro-
vascular complications. Concerning to our knowledge,
there is no systematic studies about the effects of life
context on board on the linkage between depression and
diabetes.
We hypothesized that diabetic patients would have
additional predictors for depression and anxiety, not just
predictors from diabetes-related stresses alone. We ex-
amined diabetes with four indicators of disease: time
since diagnosis, BMI, HbA1C and number of patient
self-reported co morbidities, which can serve as diabe-
tes-related stress. The diabetic patients were mean age of
43±8.2 years, BMI score 30±8.2, the mean duration of di-
abetes 5.9±3.9 years. They were treated with diet and
oral glucose lowering agents, 36 patients with sulfonilu-
reas and 16 with metformin. We use the self-report mea-
sures for depression (BDI) and anxiety (STAI 1, STAI 2).
In this study, we have observed diabetic seafarers-spe-
cific differences in the relationship between symptoms of
depression and anxiety and the performance of aspects of
seafarers-life conditions (years on board, duration of
shipping during one year). The diabetic type 2 patients
had more then twice higher proportion of depression
(34%) and anxiety (46%) compared to healthy seafarers.
This is comparable with studies on depression and anxi-
ety among diabetic patients without the investigating
the influence of occupational circumstances1,2,5,16,17. The
selected risk factors for depression were duration of dis-
ease, degree of obesity and level of glycaemic control. The
longer duration of shipping routes (over 6 months) was
observed to significantly associate with depression and
anxiety among diabetic seafarers. One possible explana-
tion is that diabetes mellitus is an additional factor for
stress on work, because is chronic, progressive disease
associated with various complications and high morbid-
ity and mortality. Medical assistance to seafarers is very
variable and depends of many various factors (general
and local). The severity of depression and anxiety, in both
groups, had been linked to the longer duration of ship-
ping route during one year.
The periodic health examination systemmust be used
to prevent development of all chronic diseases, like dia-
betes mellitus type 2 with its all complications26–30. Per-
forming additional screening tests for depression and











Fig. 2. Proportion of diabetic and healthy seafarers reporting
moderate-severe symptoms of anxiety (**p<0.001 versus control).
anxiety in routine work help us to prompt detection and
treatment of both, diabetes and disease-related psycho-
logical reactions and mental disorders. The utility of con-
sidering many life stresses can prevent negative behav-
ioral and emotional outcomes31.
The effects of general life, work and diabetes-related
stresses are experienced cumulatively as general psycho-
logical distress and not only as depression in seafarer’s
type 2 diabetic patients.
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U^ESTALOST DEPRESIJE I ANKSIOZNOSTI KOD POMORACA S TIPOM 2 [E]ERNE BOLESTI
S A @ E T A K
Depresija i anksioznost su pridru`ene bolesti uz tip 2 {e}erne bolesti kao psiholo{ka reakcija na razvoj ove kroni~ne
metaboli~ke bolesti. Cilj studije je odre|ivanje u~estalosti depresije i anksioznosti kod pomoraca s tipom 2 {e}erne
bolesti. U studiju su uklju~ena 52 pomorca s tipom 2 {e}erne bolesti lije~enih dijetom i peroralnim hipoglikemicima, te
56 zdravih pomoraca, koji su testirani za depresiju s Beckovim upitnikom za depresiju (BDI) i upitnikom za anksioznost
State-Trait Anxiety Inventory (STAI 1, STAI 2). Depresija (BDI>18,5) i anksioznost (STAI<28,5) su bili signifikantno
vi{i u skupini pomoraca lije~enih od {e}erne bolesti tip 2 u odnosu na kontrolnu skupinu (vi{e od 30%). Signifikantna
korelacija je uo~ena izme|u depresije i trajanja {e}erne bolesti, stupnja preuhranjenosti, lo{e glikemi~ke kontrole
(HbA1C>8%) i dulje vremensko trajanje plovidbe (preko 6 mjeseci). Depresija i anksioznost su vi{e prisutne u skupini
oboljelih pomoraca u odnosu na skupinu zdravih pomoraca.
